Anti-fugetactic agent and anti-cancer agent combination therapy and compositions for the treatment of cancer
US11305017B2 · kind B2 · utility
0Cited by
27References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 5, 2019 |
| Grant date | Apr 19, 2022 |
| Priority date | — |
| Expiry date | Aug 5, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K16/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention described herein relates to methods and compositions for treating cancer in a patient or a tumor cell by administering an effective amount of an anti-fugetactic agent and an additional anti-cancer agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.